- Home
- IPSC vs JSPR Comparison
IPSC vs JSPR Comparison
Compare IPSC & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- JSPR
- Stock Information
- Founded
- IPSC 2019
- JSPR 2018
- Country
- IPSC United States
- JSPR United States
- Employees
- IPSC N/A
- JSPR N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IPSC Health Care
- JSPR Health Care
- Exchange
- IPSC Nasdaq
- JSPR Nasdaq
- Market Cap
- IPSC 42.2M
- JSPR 47.6M
- IPO Year
- IPSC 2021
- JSPR N/A
- Fundamental
- Price
- IPSC $0.49
- JSPR $2.80
- Analyst Decision
- IPSC Strong Buy
- JSPR Buy
- Analyst Count
- IPSC 5
- JSPR 12
- Target Price
- IPSC $3.33
- JSPR $30.78
- AVG Volume (30 Days)
- IPSC 698.6K
- JSPR 215.8K
- Earning Date
- IPSC 08-14-2025
- JSPR 08-13-2025
- Dividend Yield
- IPSC N/A
- JSPR N/A
- EPS Growth
- IPSC N/A
- JSPR N/A
- EPS
- IPSC N/A
- JSPR N/A
- Revenue
- IPSC $114,128,000.00
- JSPR N/A
- Revenue This Year
- IPSC $1,589.94
- JSPR N/A
- Revenue Next Year
- IPSC N/A
- JSPR N/A
- P/E Ratio
- IPSC N/A
- JSPR N/A
- Revenue Growth
- IPSC 5491.77
- JSPR N/A
- 52 Week Low
- IPSC $0.34
- JSPR $2.27
- 52 Week High
- IPSC $1.86
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- IPSC 37.35
- JSPR 39.48
- Support Level
- IPSC $0.46
- JSPR $2.91
- Resistance Level
- IPSC $0.55
- JSPR $3.05
- Average True Range (ATR)
- IPSC 0.04
- JSPR 0.16
- MACD
- IPSC -0.00
- JSPR 0.05
- Stochastic Oscillator
- IPSC 25.00
- JSPR 37.04
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.